I arrive at the same conclusion, why would you add late breaking science and then announce:
"So far nothing good has happened but things could change in 9 months, thanks for coming."
Amarin always seems to be a case of: look at something logically the results should be positive for Amarin, and then between then and that positive event the stock flops around like a fish on land and then the positive result actually happens......and then dilution and insider sales..LOL
Could Amarin get the interim results from the scientists doing the study, present to Adcom panel and FDA with caveat the details cannot be publicly released until AHA but panel and FDA should have info for Adcom? Is that even a thing that remotely can happen?
Typical Amarin weirdness in that MOA will be a big question at Adcom and a couple days later evidence may come out that shows at least one MOA that has strong positive for Amarin.
November and December can't come fast enough, would it be ironic for FDA to hound on mineral oil, ask panel to vote on MO effect and then a few days later have evaporate show high level of success at 9 months.
I could see this whacked out scenario playing out: ADCOM docs released, includes vote on whether MO invalidated results, stock tanks to 12, Adcom vote says no by a strong majority but FDA still made it a vote so not sure what will they do, stock recovers to 15, Evaporate says reached 9 month success rate but want to see what happens at 18 months, stock to 18.
Then we wait 2 months for FDA as we debate will they require MO study or not, AND then they approve expanded label BUT require study on MO effect and if negative will revisit approval.....and a year later we're all still here doing the same thing over and over....the nightmare that will never end.
I can't believe this whole saga cannot be a best selling book some day.
